Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FavId and GM-CSF in Progressive B-cell Non-Hodgkin's Lymphoma
NCT00104819Phase 2Terminated
- Sponsor
- Favrille, Inc.
- Start
- Sep 2004
- Primary completion
- Jun 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of FavId in follicular lymphoma (FL), sponsored by Favrille, Inc.. Started Sep 2004; status: terminated.
02
Drugs
FavId
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00104819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104819.